Celltrion | 068270 - Stammkapital

Aktienkurs
188,800.00
Täglich Wechseln
-6,300.00 -3.23%
Monatlich
-9.67%
Jährlich
22.60%
Q2 Prognose
177,698.56




Stammkapital Veränderung Datum
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Celltrion KRW 218.61M 162.21K 2025-12
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Moderna USD 391M 2M 2025-09
Organon & Co USD 260.32M 333K 2025-12
Revvity USD 111.8M 1.57M 2026-03
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Viatris USD 1.16B 5.27M 2026-03
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12